Impacting Radiotherapy Safety and QA with Device Improvements Benedick A Fraass, PhD, FAAPM, FASTRO, FACR Allen S. Lichter Professor of Radiation Oncology.

Slides:



Advertisements
Similar presentations
Jeff Michalski, MD, MBA, FACR Professor and Vice-Chair Department of Radiation Oncology Washington University School of Medicine.
Advertisements

DICOM Conference - Singapore April 1, 2005
Safety and Extrapolation Steven Hirschfeld, MD PhD Office of Cellular, Tissue and Gene Therapy Center for Biologics Evaluation and Research FDA.
Radiation Therapy Safety Standards
FDA-QA-DAS/2010 FDA’s Public Meeting: Device Improvements to Reduce the Number of Under-doses, Over-doses, and Misaligned Exposures from Therapeutic Radiation.
Real-time tumor tracking with preprogrammed dynamic MLC motion and adaptive dose-rate regulation B.Y Yi, S. Han-Oh, F. Lerma, B. Berman, C. Yu.
Quality Assurance: Manufacturer & Clinical Aspects  Alan Cohen, M.S. DABR  Paul Naine, MSc. MIPEM  Jim Schewe, PhD, DABMP Accuray Incorporated Elekta.
WELCOME!!! FDA & MITA RT Meeting
Radiotherapy Quality Assurance
By Katharine Morton SOFTWARE AND EQUIPMENT FOR REHAB PLACES.
COMPUTERS AND RADIATION THERAPY/ONCOLOGY Lydia Eichler CIS 109.
11. – , Athens 8th European Conference on Medical Physics DOSIMETRY AUDITS IN RADIOTHERAPY IN THE CZECH REPUBLIC Irena Koniarová Daniela Ekendahl.
What Happens in the days before treatment ?
 Quality & Safety Considerationsin Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.
Radiation Therapy Manufacturers FDA Public Meeting June 10, 2010 Device Improvements To Reduce the Number of Under-Doses, Over-Doses and Misaligned Exposures.
Quality Control in Radiation Therapy, A New Concept: Dosimetry Check
Pathfinding Session: Radiotherapy Treatment Planning, Delivery, and Record & Verify Systems IHE North America Webinar Series 2008 Colin Field on Behalf.
Challenges for TPS Chunhua Men Elekta Software, Treatment Planning System BIRS Workshop Banff, Canada 3/12/2011.
Quality Assurance for a modern treatment planning system
The days before Treatment
TESTING.
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
BIOTECH SUPPLY October 8-9, 2012 Crowne Plaza, Foster City, CA Solving the Missing Link Between Forecasting and ERP in Clinical Supply Optimization Michelle.
Sandy Lum University of Toronto Candidate MHSc in Clinical Engineering The Totally Integrated Electronic Patient Record (EPR)
FDA Public Meeting Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures From Therapeutic Radiation James M. Galvin,
What is a life cycle model? Framework under which a software product is going to be developed. – Defines the phases that the product under development.
Comparison of Clinical Parameters for Proton Therapy in the United States Paige Summers, MS.
 To explain the importance of software configuration management (CM)  To describe key CM activities namely CM planning, change management, version management.
1 4D: Adaptive Radiotherapy & Tomotherapy Bhudatt Paliwal, PhD Professor Departments of Human Oncology & Medical Physics University of Wisconsin Madison.
Surface dose prediction and verification for IMRT plans using line dose profiles † Ronald E. Berg, † Michael S. Gossman and ‡ Stephen J. Klash † Erlanger.
The RPC Proton Therapy Approval Process
FDA Public Meeting: Device Improvements to Reduce the Number of Under-doses and Misaligned Exposures from Therapeutic Radiation.
Chapter 1: Introduction Omar Meqdadi SE 2730 Lecture 1 Department of Computer Science and Software Engineering University of Wisconsin-Platteville.
1 MODERNIZATION OF BELARUSIAN STATISTICS _________________________________________________ IMPLEMENTATION OF THE PROCESS APPROACH IN ORGANIZING THE STATISTICAL.
Something We Learned about Computer Supported Cooperative Work in Software Engineering Tangqiu Li, Zongkai Lin Xiamen University, China.
Institute for Advanced Radiation Oncology
Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili
Integrating the Health Care Enterprise- Radiation Oncology Use Case: In Vivo Patient Dosimetry Editor: Juan Carlos Celi - IBA Reviewer: Zheng Chang – Duke.
An Ontology-based Framework for Radiation Oncology Patient Management DL McShan 1, ML Kessler 1 and BA Fraass 2 1 University of Michigan Medical Center,
1 Radiotherapy, hadrontherapy and treatment planning systems. Faiza Bourhaleb INFN-Torino University Med 1er-Morocco  Radiotherapy  Optimization techniques.
On-Time Prevention Program for Long Term Care: Clinical Decision Support On-Time Prevention Program for Long Term Care: Clinical Decision Support William.
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
Software Engineering 2004 Jyrki Nummenmaa 1 BACKGROUND There is no way to generally test programs exhaustively (that is, going through all execution.
K. Pulliam, MS 1,2., D Followill, PhD 2., L Court, PhD 2., L Dong, PhD 3., M Gillin, PhD 2., K Prado, PhD 3., S Kry, PhD 2 1 The University of Texas Graduate.
Somvilai Mayurasakorn, MD. Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang Mai University Somvilai Mayurasakorn, MD. Division.
Software Quality Assurance and Testing Fazal Rehman Shamil.
Automated QA at Breast Cancer Rounds – A process to improve efficiency and quality of patient care Dr. Kathy Rock Breast Cancer Clinical Fellow Rock K,
CHC Annual Conference 28 June 2012 DRIVING IMPROVEMENT THROUGH INDEPENDENT AND OBJECTIVE REVIEW 1 Healthcare Inspectorate Wales Our focus over the next.
EPID BASED QA The future ? Motivation – reduce QA burden Too much QA.
This has been created by QA InfoTech. Choose QA InfoTech as your Automated testing partner. Visit for more information.
IHE-RO 2008 Managed Workflow Profiles Bruce Curran Assistant Professor / Univ of Michigan.
Retroactive Calculation of TLD and Film Dose in Anthropomorphic Phantom as Assessment of Updated TPS Performance H. Alkhatib 1, S. Oves 1, B. Tsang 1,
Medical Dosimetry Presented by (Add Hospital name) in conjunction with The American Association of Medical Dosimetrists.
Understanding Radiation Therapy Lecturer Radiological Science
Increasing use of automated systems
Software Engineering (CSI 321)
Kasey Etreni BSc., MRT(T), RTT, CTIC
Second Generation Radiotherapy C-Arm RT Treatment Modalities
Principles of Information Systems Eighth Edition
Introduction Characteristics Advantages Limitations
INTRODUCTION RESULTS DATA ANALYSIS DISCUSSION METHODS REFERENCES
Linac Commissioning Overview
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Second Generation Radiotherapy C-Arm RT Treatment Modalities
HOW RO-ILS HELP DOSIMETRISTS TO IMPROVE PATIENT SAFETY
Week 13: Errors, Failures, and Risks
Component 11 Unit 7: Building Order Sets
CRITICAL CARE NURSES CHAPTER----QUALITY IN CRITICAL CARE.
Adapting Agile in Pharmaceutical Industries
Presentation transcript:

Impacting Radiotherapy Safety and QA with Device Improvements Benedick A Fraass, PhD, FAAPM, FASTRO, FACR Allen S. Lichter Professor of Radiation Oncology and Director of Radiation Physics, Dept. of Radiation Oncology, University of Michigan Chair: ASTRO Multidisciplinary QA Subcommittee AAPM Science Council, Therapy Physics Committee, TG100, Chair: Research Committee FDA Public Meeting: Device Improvements to Reduce the Number of Under-Doses, Over- Doses, and Misaligned Exposures From Therapeutic Radiation

Goal: Describe several issues in which vendor or FDA efforts may help us improve patient safety and QA efficiency and effectiveness Impacting Radiotherapy Safety and QA with Device Improvements

Need 1: Process-based Analysis + QA MLC Leaf Sequencing Tx Delivery Planning, Prep AutomatedTx Delivery, Verification e-chart, Billing Patient Setup w/ Imaging Inverse Planning Imaging, Targets, Normal Anatomy, Beams Dose Calcs Plan Evaluation Download to Delivery System Patient- specific IMRT QA RT process is complex: we need process-oriented QA to deal with that complexity The vendor can never “provide” all the QA needed for each potential technique Vendors, regulators and clinicians all must recognize that we need more than just QA tests for machine features

Patient-specific IMRT QA Need 2: Flexibility to put together new and more effective QA processes MLC Leaf Sequencing Tx Delivery Planning, Prep AutomatedTx Delivery, Verification e-chart, Billing Patient Setup w/ Imaging Inverse Planning Imaging, Targets, Normal Anatomy, Beams Dose Calcs Plan Evaluation Download to Delivery System Patient-specific IMRT QA IMRT Leaf Sequencing Download to Delivery System Patient-specific IMRT QA

Typical Patient-Specific IMRT QA Check: Apply IMRT plan to QA phantom Deliver plan to QA phantom + ion chamber Check each beam’s intensity (+ dose distrib?) vs calc (with film or 2-D electronic system) Result: Total dose at one point + confirmation of beam intensities – after lots of work! Need 2: Flexibility to put together new and more effective QA processes

Automating Patient-Specific IMRT QA: Need 2: Flexibility to put together new and more effective QA processes By having the flexibility to combine devices and techniques in novel ways:

Litzenberg Automating Patient-Specific IMRT QA: Need 2: Flexibility to put together new and more effective QA processes

When we are driven by clinical needs to look for better ways to do things – we need the flexibility to do things that individual vendors will not have the resources or motivation to do Automating Patient-Specific IMRT QA: Need 2: Flexibility to put together new and more effective QA processes 4%

The clinical workflow is directly related to the QA needed for modern RT: modifications can make crucial improvements MLC Leaf Sequencing Tx Delivery Planning, Prep Automated Tx Delivery, Verification e-chart, Billing (Automated) Patient Setup w/ Imaging Prescription, Inverse Planning MLC Leaf Sequencing Download to Delivery System Patient- specific IMRT QA Imaging, Targets, Normal Anat Beam Arrangement+ Technique Dose to Points Calcs Plan Evaluation Need 3: Flexibility to rearrange clinical process workflow If we identify a process change that can improve safety/quality, we need to have flexibility to implement that change We need better workflow adjustment tools...

Need 4: Vendor-provided QA Tools, Updates Vendors must make new QA-related devices, tools, methods quickly accessible to users Note: QA devices must be used routinely before their value, or best uses can be known or proven FDA: A slow or difficult marketing approval process can make potential products impossible to get, test, develop or implement This is particularly problematic for software enhancements or modifications that can fix important bugs or make a hardware device or technique useful

MLC Leaf Sequencing Tx Delivery Planning, Prep Automated Tx Delivery, Verification e-chart, Billing (Automated) Patient Setup w/ Imaging Prescription, Inverse Planning MLC Leaf Sequencing Download to Delivery System Patient- specific IMRT QA Imaging, Targets, Normal Anat Beam Arrangement+ Technique Dose to Points Calcs Plan Evaluation Tx delivery QA and monitoring must involve RTTs and convey both qualitative + quantitative info easily and clearly Monitoring must be integrated for efficiency Monitoring must be independent for safety Need 5: Treatment Delivery QA and Monitoring: Integrated or Independent ?

about to move move finished UM CCRS System: IJROBP 95 MLC Leaf Sequencing Tx Delivery Planning, Prep Automated Tx Delivery, Verification e-chart, Billing (Automated) Patient Setup w/ Imaging Prescription, Inverse Planning MLC Leaf Sequencing Download to Delivery System Patient- specific IMRT QA Imaging, Targets, Normal Anat Beam Arrangement+ Technique Dose to Points Calcs Plan Evaluation (Relatively) independent verification is possible: Need 5: Treatment Delivery QA and Monitoring: Integrated or Independent ?

Need 6: Collaborative + independent input into vendor design, hazard analyses, usability, and workflow efforts… Detailed checks of software or hardware design at the end of the product development process are too late to fix problems or weaknesses Vendors should incorporate independent input (by clinically knowledgeable experts) into design, hazard analyses, test plan designs, usability The earlier this happens in the development process, the better for everyone !

Need 7: Vendor support for user groups for sharing of QA methods, issues Users of a given vendor’s system all have much in common: QA needs and techniques Experience with system-specific issues Knowledge how to solve or avoid problems Improvements to suggest Vendors should support user’s groups which help with sharing of this info!

Support process-based analysis and QA Flexibility for new + more effective QA processes Flexibility to rearrange clinical process workflow More vendor-provided QA tools + methods Integrated vs independent monitoring Vendors need collaborative + independent input into design, hazard analysis, usability, workflow Support of user groups for QA: sharing processes, methods, issues Impacting Radiotherapy Safety and QA with Device Improvements